Biomarin Pharmaceutical Inc (BMRN)
Quick ratio
| Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash | US$ in thousands | 1,250,110 | 1,213,820 | 1,048,800 | 942,842 | 675,448 | 972,150 | 746,996 | 755,127 | 785,414 | 694,381 | 580,074 | 724,531 | 761,515 | 619,802 | 605,440 | 587,276 | 617,143 | 641,533 | 667,313 | 649,158 |
| Short-term investments | US$ in thousands | 227,731 | 218,309 | 223,532 | 194,864 | 254,996 | 252,201 | 299,584 | 318,683 | 340,431 | 476,577 | 572,017 | 567,006 | 512,253 | 489,945 | 450,798 | 426,599 | 462,333 | 481,864 | 420,178 | 416,228 |
| Receivables | US$ in thousands | 790,266 | 855,855 | 739,177 | 660,535 | 777,547 | 691,232 | 637,163 | 633,704 | 572,498 | 610,222 | 597,913 | 461,316 | 419,622 | 466,507 | 430,147 | 373,399 | 374,937 | 424,419 | 396,097 | 448,351 |
| Total current liabilities | US$ in thousands | 798,438 | 684,247 | 628,213 | 606,988 | 715,658 | 1,067,340 | 1,087,900 | 1,177,020 | 1,163,220 | 597,231 | 598,231 | 588,884 | 521,020 | 464,727 | 490,418 | 539,822 | 514,898 | 443,344 | 430,035 | 492,548 |
| Quick ratio | 2.84 | 3.34 | 3.20 | 2.96 | 2.39 | 1.79 | 1.55 | 1.45 | 1.46 | 2.98 | 2.93 | 2.98 | 3.25 | 3.39 | 3.03 | 2.57 | 2.82 | 3.49 | 3.45 | 3.07 |
September 30, 2025 calculation
Quick ratio = (Cash + Short-term investments + Receivables) ÷ Total current liabilities
= ($1,250,110K
+ $227,731K
+ $790,266K)
÷ $798,438K
= 2.84
Peer comparison
Sep 30, 2025
Company name
Symbol
Quick ratio
Biomarin Pharmaceutical Inc
BMRN
2.84
Arrowhead Pharmaceuticals Inc
ARWR
4.74
Regeneron Pharmaceuticals Inc
REGN
3.19